LEXINGTON, Mass., March 12, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers provided a corporate update and reported financial results for the fourth quarter and full year of 2019.

OLDWICK, N.J., March 12, 2020 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today reported financial results for the fourth quarter and full year ended December 31, 2019.

ST. LOUIS, March 12, 2020 /PRNewswire/ -- Centene (NYSE: CNC) today announced that it is extending coverage for COVID-19. This important step is being taken in partnership with other major insurers and with the support of the White House Coronavirus Task Force.  Centene intends to cover COVID-19 testing and screening services for Medicaid, Medicare

LOS GATOS, Calif., March 12, 2020 /PRNewswire/ -- NuVera Medical, Inc., a portfolio company of Shifamed LLC, has been awarded the "Top 25 Cardiac Imaging Leaders 2020" honor from Cardiology2.0 Magazine as recognition for the impact the company is making in the cardiac imaging space."NuVera is reinventing the imaging modality for complex cardiac transcatheter

New Approach Entails a Defined Antibody Combination Targeting Multiple Epitopes and Mechanisms of Viral Evasion VICTORIA, March 12, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF), following its announcement to develop innovative treatments against the new coronavirus, SARS-C

OLDWICK, N.J., March 12, 2020 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced positive top-line results from the Phase 1b portion of the PREVAIL (PRV-3279 EVAluation In Lupus) study evaluating PRV-3279 in healthy

SOUTH SAN FRANCISCO, Calif., March 12, 2020 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, today announced that Merck, known as MSD outside the U.S. and

CARLSBAD, Calif., March 12, 2020 /PRNewswire/ -- Thermo Fisher Scientific announced today it has signed an agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to co-develop a companion diagnostic (CDx) in oncology. The CDx will support clinical trial enrollment globally. Under the agreement, Thermo Fishe

PITTSBURGH, March 12, 2020 /PRNewswire/ -- The United States Army,

MONTREAL and SARASOTA, FL, March 12, 2020 /PRNewswire/ - CAE Healthcare announced today that it will offer complimentary webinars and a downloadable scenario throughout the months of March and April to help caregivers practice personal safety procedures and initial patient assessment related to coronavirus. These webinars and scenari